Evaluation of a low-cost, low-power syringe pump to deliver magnesium sulfate intravenously to pre-eclamptic women in a Malawian referral hospital

Abstract

BackgroundMagnesium sulfate is an affordable and effective treatment for pre-eclampsia and eclampsia. In settings where infusion pumps are not available to regulate the flow rate of intravenous delivery, healthcare providers must administer magnesium sulfate (MgSO4) via time-consuming and painful, large-volume intramuscular injections. As an alternative to costly commercially available syringe pumps, we developed AutoSyp, an accurate, low-cost, and low-powered syringe pump designed to meet the needs and constraints these low-resource settings. This paper describes results of a pilot study to evaluate the feasibility of using AutoSyp to administer MgSO4 intravenously to women suffering from pre-eclampsia at a referral hospital in Blantyre, Malawi.MethodsAutoSyp was programmed to deliver MgSO4 following the Zuspan regimen to pregnant and post-partum women suffering from pre-eclampsia at Queen Elizabeth Central Hospital in Blatnyre, Malawi. Given the selection of either loading or maintenance dose on AutoSyp’s user interface, the flow rate was automatically programmed to dispense 60 mL/h or 5 mL/h of 20% MgSO4 solution, respectively. During each treatment, the dispensed volume was automatically calculated by the device based on the plunger position and stored on a computer for accuracy analysis of the mean flow rate and total volume delivered. The clinical results for both the loading and maintenance dose administrations were compared to the device’s accuracy during tests performed in the laboratory setting.ResultsTwenty-two women were enrolled in this study. In both the clinical and laboratory settings, the mean flow rate errors for the loading and maintenance dose infusions were under 2%. During 466 h of testing, the device sounded 129 occlusion alarms across 14 subjects. Of these, 71 alarms were false positives.ConclusionResults of this study support the use of AutoSyp as a less painful and accurate means of MgSO4 administration in clinical environments that lack infusion systems.There were a large number of false alarms in the current system which will be addressed in future designs. AutoSyp maintains the comfort of intravenous MgSO4 administration, but unlike commercially available syringe pumps, it is capable of operating with a variety of syringe brands and sizes and requires no additional consumables. AutoSyp’s appropriate design will benefit its implementation and sustained use in low-resource settings.Trial RegistrationTrial registered prospectively on November 18, 2014 with ClinicalTrials.gov (NCT02296931)

Defining the Current Deployment of Neonatal Infusion Pumps in Low- and Lower-Middle-Income Countries: A Rapid Review

“…Other types of medical devices, designed for use in LLMICs, have been proven effective in helping to achieve this. [30][31][32][33] Several designs of infusion pumps have already been developed, [34][35][36][37][38] however none have been widely deployed yet. Trialing the use of specifically designed infusion pumps could help improve the accessibility of quality of infant hydration, nutrition and drug delivery.…”

Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia

“…Another method is a syringe pump known as AutoSyp. This invention was designed to be low-cost, accurate, and low-powered to bypass the cost restrictions in countries with low GNI [ 44 ]. Therefore, it has been established that the drug MgSO4 itself is cost-effective, but the means of administering it is expensive.…”

A Simple Approach for Controlling an Open-Source Syringe Pump

“…The working principle of this pump was based on the controlled-release of a loaded spring mechanism through a stepper motor which was driven by a microcontroller. Effectiveness of this syringe pump system was later tested via intravenously delivering magnesium sulfate to patients with pre-eclamtic condition [12]. In total, 22 women patients were included in a 466-hour long testing period, and lower than 2% errors were recorded in the applied flow rates.…”